Vosaroxin significantly increases levels of mitochondrial ROS and lipid peroxidation, and induces mitochondrial swelling and ATP generation by acting through the AMPK/Sirt3/HIF-1 pathway in the cervical cancer cell line HeLa122. This evidence concerns the gene HIF1A and cervical carcinoma.